Skip to content

Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, sold MPLT on Jul 15, 2026

Data as of Oct 16

▼ SELL$682K18,950 shares at $36.00Christopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.
Watch MPLT
Traded
Jul 15, 2026
Disclosed
Jul 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, sold MPLT on Jul 15, 2026TRADEDDISCLOSED
MPLTSimilar stocks (XLV — its sector index fund), rebased to MPLT's price on the disclosure day
MPLT since disclosure
−79.7%
after the sale
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund

Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$636Kdisclosed Jul 17 · filed the same day
  2. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$3.5Kdisclosed Jul 17 · filed 1 day after the trade
  3. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$1.5Mdisclosed Jul 17 · filed 1 day after the trade
  4. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$1Mdisclosed Jul 17 · filed 1 day after the trade
  5. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$3.4Kdisclosed Jul 17 · filed 2 days after the trade
  6. ▼ SELLChristopher A. Kroeger Chief Executive OfficerMPLT MapLight Therapeutics, Inc.$1.6Mdisclosed Jul 17 · filed 2 days after the trade

See every trade on MPLT →